Drug consumption rooms are effective to reduce at-risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study

L. LALANNE ; P. ROUX ; C. DONADILLE ; L. BRIAND MADRID ; I. CELERIER ; C. CHAUVIN ; N. HAMELIN ; C. KERVRAN ; G. MARADAN ; M. AURIACOMBE ; M. JAUFFRET-ROUSTIDE ; COSINUS Study Group | 2024
Dans Addiction (Vol.119, n°1, January 2024) Article : Périodique

Aims: The primary aim of this study was to evaluate the impact of drug consumption rooms (DCRs) in France on injection equipment-sharing, while the secondary aims focused upon their impact on access to hepatitis C virus (HCV) testing and opioid [...]

Plus d'info

Ajouter à la sélection

Lien externe

Episodic memory and inhibitory control in people who inject substances results of cohort COSINUS study

L. LALANNE ; S. KIRCHHERR ; M. AUDRAN ; S. DE DINECHIN ; N. HAMELIN ; C. CHAUVIN ; L. BRIAND MADRID ; C. KERVRAN ; M. AURIACOMBE ; P. ROUX ; M. JAUFFRET-ROUSTIDE ; COSINUS Study Group | 2025
Dans BMC Psychiatry (Vol.25, 2025) Article : Périodique

BACKGROUND: Cognitive disorders associated with addictive disorders are well established in the literature for numerous substances and behaviours. Very few studies have examined the effect of polydrug use on cognitive functioning. These studies [...]

Plus d'info

Ajouter à la sélection

Lien externe

Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort

P. ROUX ; M. JAUFFRET-ROUSTIDE ; C. DONADILLE ; L. BRIAND MADRID ; C. DENIS ; I. CELERIER ; C. CHAUVIN ; N. HAMELIN ; G. MARADAN ; M. P. CARRIERI ; C. PROTOPOPESCU ; L. LALANNE ; M. AURIACOMBE ; COSINUS Study Group | 2023
Dans International Journal of Epidemiology (Vol.52, n°2, April 2023) Article : Périodique

Background: The effectiveness of drug consumption rooms (DCRs) for people who inject drugs (PWID) has been demonstrated for HIV and hepatitis C virus risk practices, and access to care for substance use disorders. However, data on other health-r[...]

Plus d'info

Ajouter à la sélection

Lien externe

Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol

M. AURIACOMBE ; P. ROUX ; L. BRIAND MADRID ; S. KIRCHHERR ; C. KERVRAN ; C. CHAUVIN ; M. GUTOWSKI ; C. DENIS ; M. P. CARRIERI ; L. LALANNE ; M. JAUFFRET-ROUSTIDE ; COSINUS Study Group | 2019
Dans BMJ Open (Vol.9, n°2, February 2019) Article : Périodique

Introduction: The high prevalence of hepatitis C and the persistence of HIV and hepatitis C virus (HCV) risk practices in people who inject drugs (PWID) in France underlines the need for innovative prevention interventions. The main objective of[...]

Plus d'info

Ajouter à la sélection

Lien externe

Medications for opioid use disorder in people who inject substances: Reflection on the potential place of morphine sulfate as substitution treatment? Results of COSINUS cohort study

L. LALANNE ; J. R. DAVALOS ; M. AUDRAN ; N. HAMELIN ; C. CHAUVIN ; L. BRIAND-MADRID ; C. KERVRAN ; S. KIRCHHERR ; M. AURIACOMBE ; P. ROUX ; M. JAUFFRET-ROUSTIDE ; COSINUS Study Group | 2025
Dans Substance Use and Misuse (Vol.60, n°3, 2025) Article : Périodique

BACKGROUND: Opioid Use Disorder (OUD) often provokes dramatic consequences in terms of increased morbi-mortality. Two medications have mainly been worldwide used for OUD (MOUD), buprenorphine and methadone. Recently, however, some reports have h[...]

Plus d'info

Ajouter à la sélection

Lien externe

Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study

P. ROUX ; A. FAYE ; L. SAGAON-TEYSSIER ; C. DONADILLE ; L. BRIAND MADRID ; M. P. CARRIERI ; G. MARADAN ; M. JAUFFRET-ROUSTIDE ; L. LALANNE ; M. AURIACOMBE ; COSINUS Study Group | 2025
Dans Drug and Alcohol Review (Vol.44, n°1, January 2025) Article : Périodique

INTRODUCTION: The co-use of stimulants and opioids, including opioid agonist treatment (OAT), is very prevalent worldwide. A large body of data exists on the association between stimulant use and its health complications, and on OAT effectivenes[...]

Plus d'info

Ajouter à la sélection

Lien externe